OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
61
Results
Show all
Save search
Copy query
Show results for
Unknown
(61)
Publication Date
Release Date
2021
(10)
2022
(8)
2018
(7)
2015
(7)
2023
(6)
2025
(5)
2019
(5)
2024
(3)
2020
(3)
2017
(3)
2011
(2)
2014
(1)
2008
(1)
Previous
page
1 / 7
You're on page
1
page
2
page
3
page
4
page
5
page
6
page
7
Next
page
Sort
by:
Relevance
Page size
10
20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years.
Not available
S-EPMC5734609
|
biostudies-literature
Cite
Associations between neuromelanin depletion and cortical rhythmic activity in Parkinson's disease.
Not available
S-EPMC11884654
|
biostudies-literature
Cite
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
Not available
S-EPMC7787219
|
biostudies-literature
Cite
Brain charts for the human lifespan.
Not available
S-EPMC9021021
|
biostudies-literature
Cite
CHD3 helicase domain mutations cause a neurodevelopmental syndrome with macrocephaly and impaired speech and language.
Not available
S-EPMC6218476
|
biostudies-literature
Cite
Rheumatoid arthritis susceptibility loci at chromosomes 10p15, 12q13 and 22q13.
Not available
S-EPMC2662493
|
biostudies-literature
Cite
Finding Diagnostically Useful Patterns in Quantitative Phenotypic Data.
Not available
S-EPMC6848993
|
biostudies-literature
Cite
Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study.
Not available
S-EPMC11108802
|
biostudies-literature
Cite
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.
Not available
S-EPMC8362592
|
biostudies-literature
Cite
Prevalence and risk factors for delirium in critically ill patients with COVID-19 (COVID-D): a multicentre cohort study.
Not available
S-EPMC7832119
|
biostudies-literature
Cite
Previous
page
1 / 7
You're on page
1
page
2
page
3
page
4
page
5
page
6
page
7
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets